Article info

Download PDFPDF

Extended report
Improvements in productivity at paid work and within the household, and increased participation in daily activities after 24 weeks of certolizumab pegol treatment of patients with psoriatic arthritis: results of a phase 3 double-blind randomised placebo-controlled study

Authors

  1. Correspondence to Professor Arthur Kavanaugh, Division of Rheumatology, Allergy and Immunology, University of California, San Diego, 9500 Gilman Drive, MC 0943, La Jolla CA 92037-0943, USA; akavanaugh{at}ucsd.edu
View Full Text

Citation

Kavanaugh A, Gladman D, van der Heijde D, et al
Improvements in productivity at paid work and within the household, and increased participation in daily activities after 24 weeks of certolizumab pegol treatment of patients with psoriatic arthritis: results of a phase 3 double-blind randomised placebo-controlled study

Publication history

  • Received January 7, 2014
  • Revised April 15, 2014
  • Accepted May 24, 2014
  • First published June 18, 2014.
Online issue publication 
December 04, 2014

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.